Sunder Biomedical Tech Co Stock

Sunder Biomedical Tech Co Forward P/E

The Forward P/E Ratio of Sunder Biomedical Tech Co (4115.TWO) as of Aug 21, 2026 is -26.28. In the previous year, Forward P/E Ratio was 14.68 — a change of -278.97% (lower).

Forward P/E

-26.28

YoY

-278.97%

Last updated:

Forward P/E Ratio of Sunder Biomedical Tech Co is 2026 -26.28 . Forward P/E Ratio of Sunder Biomedical Tech Co was 2025 14.68 . It decreases by -278.97% lower compared to the previous year.
Access this data via the Eulerpool API

Sunder Biomedical Tech Co Stock analysis

What does Sunder Biomedical Tech Co do? Sunder Biomedical Tech Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sunder Biomedical Tech Co stock

Forward P/E Ratio of Sunder Biomedical Tech Co is -26.28 in 2026.

Forward P/E Ratio of Sunder Biomedical Tech Co changed from 14.68 to -26.28, representing a -278.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Forward P/E Ratio Sunder Biomedical Tech Co since 2006 – with annual values, charts, and detailed analysis.

The Forward P/E uses estimated future earnings to value a stock. A lower forward P/E relative to the trailing P/E suggests analysts expect earnings growth.

To evaluate Forward P/E Ratio's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Forward P/E Ratio.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Forward P/E Ratio's Sunder Biomedical Tech Co with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

Valuation — Sunder Biomedical Tech Co

All Key Metrics — Sunder Biomedical Tech Co